Document is current
Any future updates will be listed below
-
Authors
Zhang, Wenhao
Gai, Yanzhi
Qiao, Mengxue
Rowicki, Michelle
Wei, Yong
Hang, Xiang
Wei, Zhengkai
Yang, He
Ye, Xifu
Ju, Hang
Lu, Yi https://orcid.org/0000-0002-1599-8593
Kang, Yibin https://orcid.org/0000-0002-1626-6730
Shen, Minhong
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82472950, 2021hwyq55)
Natural Science Foundation of Shanghai
Foundation of Shanghai Municipal Commission of Health and Family Planning
Brewster Foundation
Breast Cancer Research Foundation
American Cancer Society
Ludwig Institute for Cancer Research
- License Information
-
More Information
Article History
Received: 15 May 2025
Revised: 8 October 2025
Accepted: 22 October 2025
First Online: 18 November 2025
Competing interests
: Y.K. is a founder and chair of the scientific advisory board of KayoThera and Firebrand Therapeutics. Y.K. is the editorial board member of Signal Transduction and Targeted Therapy, but he has not been involved in the process of handling the manuscript. The other authors declare that they have no competing interests.
